Literature DB >> 8570306

Effects of combined treatment with rhDNase and airflow oscillations on spinnability of cystic fibrosis sputum in vitro.

B Dasgupta1, R P Tomkiewicz, W A Boyd, N E Brown, M King.   

Abstract

Treatment with either rhDNase or high-frequency oscillation has been shown to be effective in improving the physical and transport properties of airway secretions in cystic fibrosis (CF). The objects of this in vitro study was to examine whether combined treatment with oscillation and rhDNase results in greater change of CF sputum spinnability than either treatment by itself. Aliquots of sputum (0.4 g) from eight CF patients were subjected to the following protocols for 15 minutes and then followed for a total of 30 minutes: 1) incubation with 0.04 ml DNase 50 micrograms rhDNase/normal saline (10% dilution) at 37 degrees C to achieve 5 micrograms DNase/g of sputum final concentration; 2) airflow oscillation at 27 Hz similar to the airflow magnitude produced by a commercial high-frequency chest compression (HFCC) device; 3) negative control with no treatment; 4) positive (dilution) control, incubating with 10% saline by volume; 5) combination of DNase and oscillation, and 6) combination of saline and oscillation. For each protocol, sputum spinnability (in mm, mean +/- SD) was measured by means of a filancemeter at baseline, 15, and 30 minutes. Treatment with DNase decreased spinnability significantly more than either saline or oscillation at 15 and 30 minutes (P < 0.02 and P < 0.04, respectively). Incubation with saline or oscillation of CF sputum for 15 and 30 minutes decreased spinnability significantly compared with control. The combination of DNase and oscillation decreased spinnability significantly more than treatment with DNase alone (3.74 +/- 0.45 vs. 6.54 +/- 0.73 at 15 minutes, P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570306     DOI: 10.1002/ppul.1950200205

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

Review 1.  Physiotherapy in cystic fibrosis.

Authors:  S A Prasad; E L Tannenbaum; C Mikelsons
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.

Authors:  M S Zach
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

3.  High-frequency percussive ventilation for airway clearance in cystic fibrosis: a brief report.

Authors:  Dayton Dmello; Ravi P Nayak; George M Matuschak
Journal:  Lung       Date:  2010-07-03       Impact factor: 2.584

Review 4.  Nebulised hypertonic saline for cystic fibrosis.

Authors:  Peter Wark; Vanessa M McDonald
Journal:  Cochrane Database Syst Rev       Date:  2018-09-27

5.  Therapeutic effects of Ventolin versus hypertonic saline 3% for acute bronchiolitis in children.

Authors:  Mohammad-Ali Zamani; Mehran Movahhedi; Seyyed Mohammad-Kazem Nourbakhsh; Forouzan Ganji; Mahmoud Rafieian-Kopaei; Mahmoud Mobasheri; Abolfazl Khoshdel; Shahram Etemadifar; Majid Shirani; Zahra Keivani Hafshejani
Journal:  Med J Islam Repub Iran       Date:  2015-05-06

6.  Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice.

Authors:  Vito Terlizzi; Eleonora Masi; Michela Francalanci; Giovanni Taccetti; Diletta Innocenti
Journal:  Ital J Pediatr       Date:  2021-08-06       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.